December 18, 2024 - 00:36

MIAMI -- In a positive development for the Miami Marlins, left-handed pitcher Jesús Luzardo has announced that he is fully healthy and actively participating in his offseason training regimen. Speaking at a community event hosted by the Marlins Foundation, Luzardo expressed his enthusiasm about his recovery progress.
"I've been able to go through my normal offseason progression: throwing, running, starting to get off the mound," he shared, highlighting his commitment to returning to peak performance. Luzardo's recovery comes after a challenging season, and his current state is a welcome relief for both the player and the team's fans.
As Luzardo continues to build his strength and refine his skills, the Marlins are optimistic about his contributions in the upcoming season. His ability to throw without limitations is a promising sign, and the team is eager to see how he will impact their pitching rotation moving forward. Fans are hopeful that Luzardo's return to form will bolster the Marlins' chances in the competitive league.
July 30, 2026 - 02:45
Texas health issues alert after 4 Montgomery County residents infected with measlesTexas health authorities have issued a public health alert after four members of an unvaccinated family in Montgomery County tested positive for measles. The cases, all linked to a single household...
July 29, 2026 - 08:53
Local nonprofits call for changes at Bexar County jail over custody deaths, healthcare concernsHouston, Dallas, and San Antonio operate the three largest county jail systems in Texas. But so far this year, Bexar County has recorded the highest number of deaths among inmates in custody,...
July 28, 2026 - 17:12
Private Equity Firm Unloads Mental Health Chain Into Muni MarketA private equity firm based in Connecticut is moving to offload a network of mental health clinics and sober-living facilities, using a financing structure that taps into the municipal bond market....
July 28, 2026 - 03:52
Peptides are the latest wellness trend – but do they work?A US drug advisory committee has recently given a nod of approval to several experimental peptides, signaling a potential shift in how these compounds are viewed by regulators. Yet despite the...